MyAverix Finance
SHG · Healthcare
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671)
Drug Manufacturers - General
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-28, reported market cap is $2.74B, P/E ratio is 83.33, net margin is 13.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600671
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — FAQ
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's market cap?
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a reported market cap of $2.74B (data as of 2026-03-28).
What is 600671's P/E ratio?
The price-to-earnings (P/E) ratio for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) is 83.33 (data as of 2026-03-28).
Does Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671). Check the MyAverix Finance app for the latest dividend data.
What sector is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd in?
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) is classified in the Healthcare sector (Drug Manufacturers - General industry).
What exchange is 600671 listed on?
600671 is listed on SHG.
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd's net margin?
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) reports a net margin of 13.2% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.